Atorvastatin improves pathological changes in the aged kidney by upregulating peroxisome proliferator-activated receptor expression and reducing matrix metalloproteinase-9 and transforming growth factor-β1 levels
2011 ◽
Vol 36
(8)
◽
pp. 911-914
◽
2008 ◽
Vol 6
(1)
◽
pp. 10-20
◽
2020 ◽
Vol 19
(3)
◽
pp. 50-58
2009 ◽
Vol 301
(7)
◽
pp. 515-522
◽
2002 ◽
Vol 296
(2)
◽
pp. 267-273
◽
2005 ◽
Vol 16
(4-6)
◽
pp. 207-216
◽
2016 ◽
Vol 23
(5)
◽
pp. 362-369
◽
2017 ◽
Vol 33
(3)
◽
pp. 124-129
◽